Fatty Acid Synthase
Fatty Acid Synthase (FAS) is a multi-enzyme complex responsible for the synthesis of long-chain fatty acids. Overexpression of FAS is associated with various metabolic disorders, including obesity, diabetes, and cancer. Inhibiting FAS can reduce lipid biosynthesis and induce apoptosis in cancer cells, making it a promising target for cancer therapy and metabolic disease research. At CymitQuimica, we provide a variety of FAS inhibitors to support your research in oncology, metabolism, and therapeutic development.
Read more
trans-C75
CAS:191282-48-1
trans-C75 ((±)-C75) is an enantiomer of C75. C75 is an inhibitor of fatty-acid synthase (FASN).
Formula:
C14H22O4
Purity:
98.88%
Color and Shape:
White To Off-White Solid
Molecular weight:
254.32
Ref: TM-T10656
| 1mg | 52.00 € | ||
| 2mg | 69.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 160.00 € | ||
| 25mg | 335.00 € | ||
| 50mg | 537.00 € | ||
| 100mg | 753.00 € | ||
| 1mL*10mM (DMSO) | 108.00 € |
Estimated delivery in United States, on Friday 30 May 2025
Denifanstat
CAS:1399177-37-7
Denifanstat (FASN-IN-2) is a FASN inhibitor with selective and oral activity. Denifanstat has been used …
Formula:
C27H29N5O
Purity:
99.35% - 99.44%
Color and Shape:
Solid
Molecular weight:
439.55
Ref: TM-T15271
| 1mg | 90.00 € | ||
| 5mg | 187.00 € | ||
| 10mg | 315.00 € | ||
| 25mg | 530.00 € | ||
| 50mg | 748.00 € | ||
| 100mg | 1,064.00 € | ||
| 500mg | 2,118.00 € | ||
| 1mL*10mM (DMSO) | 216.00 € |
Estimated delivery in United States, on Friday 30 May 2025
FASN-IN-3
CAS:2097262-60-5
FASN-IN-3 is an inhibitor of fatty acid synthase (FASN).
Formula:
C24H24N4O
Purity:
97.41%
Color and Shape:
Solid
Molecular weight:
384.47
Ref: TM-T11557
| 1mg | 65.00 € | ||
| 5mg | 140.00 € | ||
| 10mg | 219.00 € | ||
| 25mg | 373.00 € | ||
| 50mg | 509.00 € | ||
| 100mg | 723.00 € | ||
| 200mg | 938.00 € | ||
| 1mL*10mM (DMSO) | 156.00 € |
Estimated delivery in United States, on Friday 30 May 2025
ACSS2-IN-2
CAS:2332820-04-7
MTB-9655 inhibits ACSS2 with 3.8 nM IC50, useful in research of viral, metabolic, neuropsychiatric diseases, …
Formula:
C21H19F2N3O4
Purity:
99.54%
Color and Shape:
Soild
Molecular weight:
415.39
Ref: TM-T60060
| 1mg | 56.00 € | ||
| 2mg | 81.00 € | ||
| 5mg | 119.00 € | ||
| 10mg | 187.00 € | ||
| 25mg | 354.00 € | ||
| 50mg | 550.00 € | ||
| 100mg | 792.00 € | ||
| 1mL*10mM (DMSO) | 131.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
IPI-9119
CAS:1346564-56-4
IPI-9119 is an orally active, selective and irreversible FASN inhibitor (IC50 = 0.3 nM).
Formula:
C24H19F2N5O5
Purity:
98.86%
Color and Shape:
Solid
Molecular weight:
495.43
Ref: TM-T36841
| 1mg | 97.00 € | ||
| 5mg | 235.00 € | ||
| 10mg | 340.00 € | ||
| 25mg | 543.00 € | ||
| 50mg | 752.00 € | ||
| 100mg | 1,017.00 € | ||
| 200mg | 1,359.00 € | ||
| 1mL*10mM (DMSO) | 255.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
Fasnall HCl
Fasnall HCl is a selective FASN inhibitor that acts through its co-factor binding sites.
Formula:
C19H23ClN4S
Purity:
99.9%
Color and Shape:
Soild
Molecular weight:
374.93
Ref: TM-T27307L
| 1mg | 96.00 € | ||
| 5mg | 197.00 € | ||
| 10mg | 319.00 € | ||
| 25mg | 502.00 € | ||
| 50mg | 702.00 € | ||
| 100mg | 947.00 € | ||
| 200mg | 1,264.00 € | ||
| 1mL*10mM (DMSO) | 221.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
FASN Protein, Human, Recombinant (His)
FASN Protein, Human, Recombinant (His) is expressed in E.
Color and Shape:
Lyophilized Powder
Molecular weight:
35.26 kDa (predicted)
Ref: TM-TMPY-06683
| 50µg | 608.00 € | ||
| 500µg | 3,832.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
BI 99179
CAS:1291779-76-4
BI 99179 is a selective and potent inhibitor of type I fatty acid synthase (FAS), …
Formula:
C23H25N3O3
Purity:
98.73%
Color and Shape:
Solid
Molecular weight:
391.46
Ref: TM-T14570
| 1mg | 40.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 106.00 € | ||
| 1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
FASN Protein, Mouse, Recombinant (His)
FASN Protein, Mouse, Recombinant (His) is expressed in E.
Color and Shape:
Lyophilized Powder
Molecular weight:
34.23 kDa (predicted)
Ref: TM-TMPY-06686
| 50µg | 608.00 € | ||
| 500µg | 3,832.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
TVB-3664
CAS:2097262-58-1
TVB-3664 is an orally active, selective, highly bioavailable fatty acid synthase inhibitor (FASN).Cost-effective and quality-assured.
Formula:
C25H23F3N4O2
Purity:
99.06% - 99.28%
Color and Shape:
Solid
Molecular weight:
468.47
Ref: TM-T17181
| 1mg | 120.00 € | ||
| 5mg | 283.00 € | ||
| 10mg | 455.00 € | ||
| 25mg | 747.00 € | ||
| 50mg | 1,103.00 € | ||
| 100mg | 1,501.00 € | ||
| 1mL*10mM (DMSO) | 310.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
VY-3-135
CAS:1824637-41-3
VY-3-135 is an orally active, stable and specific acetyl-CoA synthetase 2 (ACSS2) inhibitor.Cost-effective and quality-assured.
Formula:
C26H27N3O3
Purity:
98.56% - 99.38%
Color and Shape:
Solid
Molecular weight:
429.51
Ref: TM-T9732
| 1mg | 96.00 € | ||
| 5mg | 187.00 € | ||
| 10mg | 311.00 € | ||
| 25mg | 528.00 € | ||
| 50mg | 727.00 € | ||
| 1mL*10mM (DMSO) | 188.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
FT113
CAS:1630808-89-7
FT113 is a novel potent inhibitor of fatty acid synthase (fasn, IC50 : 213 nM),and …
Formula:
C22H20FN3O4
Purity:
97.05%
Color and Shape:
Solid
Molecular weight:
409.41
Ref: TM-T7947
| 2mg | 39.00 € | ||
| 5mg | 37.00 € | ||
| 10mg | 58.00 € | ||
| 25mg | 117.00 € | ||
| 50mg | 198.00 € | ||
| 100mg | 340.00 € | ||
| 200mg | 472.00 € | ||
| 1mL*10mM (DMSO) | 42.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
Fasnall
CAS:929978-58-5
Fasnall: FASN inhibitor with anti-tumor effect in HER2(+) breast cancer, enhanced by carboplatin.
Formula:
C19H22N4S
Purity:
90% - 99.58%
Color and Shape:
Solid
Molecular weight:
338.47
Ref: TM-T27307
| 1mg | 48.00 € | ||
| 5mg | 92.00 € | ||
| 10mg | 156.00 € | ||
| 25mg | 255.00 € | ||
| 50mg | 373.00 € | ||
| 100mg | 555.00 € |
Estimated delivery in United States, on Monday 16 Jun 2025
C75
CAS:218137-86-1
C75 is an inhibitor synthetic fatty-acid synthase (FASN) and inhibits prostate cancer cells PC3 (IC50: …
Formula:
C14H22O4
Purity:
98.84%
Color and Shape:
Solid
Molecular weight:
254.32
Ref: TM-T10657
| 1mg | 48.00 € | ||
| 2mg | 65.00 € | ||
| 5mg | 103.00 € | ||
| 1mL*10mM (DMSO) | 106.00 € |
Estimated delivery in United States, on Friday 18 Jul 2025
UCM05
CAS:1094451-90-7
UCM05 is a potent FASN and FtsZ inhibitor active against HER2+ breast cancer and B. …
Formula:
C24H16O10
Purity:
99.11%
Color and Shape:
Solid
Molecular weight:
464.38
Ref: TM-T21831
| 1mg | 40.00 € | ||
| 5mg | 88.00 € | ||
| 10mg | 137.00 € | ||
| 25mg | 274.00 € | ||
| 50mg | 432.00 € | ||
| 100mg | 638.00 € | ||
| 1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Friday 18 Jul 2025
FASN-IN-5
CAS:1309805-49-9
FASN-IN-5 is a FASN inhibitor, useful for studying cancer and metabolic diseases.
Formula:
C29H26N4O2
Purity:
99.88%
Color and Shape:
Solid
Molecular weight:
462.54
Ref: TM-T62925
| 1mg | 187.00 € | ||
| 5mg | 469.00 € | ||
| 10mg | 747.00 € | ||
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 1mL*10mM (DMSO) | 487.00 € |
Estimated delivery in United States, on Friday 18 Jul 2025
FASN-IN-1
CAS:1808260-84-5
FASN-in-1 is an effective, specific inhibitor of fatty acid synthase (FASN), a compound specifically designed …
Formula:
C18H25N3O3S2
Purity:
100% - 98.23%
Color and Shape:
Solid
Molecular weight:
395.54
Ref: TM-T11267
| 1mg | 66.00 € | ||
| 5mg | 145.00 € | ||
| 10mg | 244.00 € | ||
| 25mg | 454.00 € | ||
| 50mg | 663.00 € | ||
| 100mg | 945.00 € | ||
| 500mg | 1,890.00 € | ||
| 1mL*10mM (DMSO) | 162.00 € |
Estimated delivery in United States, on Friday 1 Aug 2025
FAS-IN-1 Tosylate
FAS-IN-1 Tosylate is an effective fatty acid synthase inhibitor;Has an IC50 of 10 nM.
Formula:
C33H35N3O7S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
649.78
Ref: TM-T11266L
| 25mg | 1,586.00 € | ||
| 50mg | 2,072.00 € | ||
| 100mg | 2,660.00 € |
Estimated delivery in United States, on Friday 1 Aug 2025
